Gene · 8324
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity. | Front Med (Lausanne) | 2023 | 37502362 | PubTator, text mining | PubMed |
| Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. | Front Oncol | 2023 | 37492478 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. | Mol Cancer | 2023 | 37488598 | PubTator, text mining | PubMed |
| WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice. | Discov Oncol | 2023 | 37486552 | PubTator, text mining | PubMed |
| Uncovering ferroptosis in Parkinson's disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products. | Front Genet | 2023 | 37485340 | PubTator, text mining | PubMed |
| The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer. | Biochem Soc Trans | 2023 | 37471270 | PubTator, text mining | PubMed |
| Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic β-catenin. | Nat Commun | 2023 | 37468468 | PubTator, text mining | PubMed |
| Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development. | Cancer Metastasis Rev | 2023 | 37460910 | PubTator, text mining | PubMed |
| The promising application of cell-cell interaction analysis in cancer from single-cell and spatial transcriptomics. | Semin Cancer Biol | 2023 | 37454878 | PubTator, text mining | PubMed |
| Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2). | J Med Chem | 2023 | 37449845 | PubTator, text mining | PubMed |
| [Modern concepts of genetic and immunohistochemical features of prolactin-secreting pituitary adenomas]. | Probl Endokrinol (Mosk) | 2023 | 37448246 | PubTator, text mining | PubMed |
| Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446204 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine RNA modification in gastric cancer. | Cell Death Discov | 2023 | 37443100 | PubTator, text mining | PubMed |
| Novel Frizzled-specific antibody-based Wnt mimetics and Wnt superagonists selectively activate WNT/β-catenin signaling in target tissues. | Cell Chem Biol | 2023 | 37413985 | PubTator, text mining | PubMed |
| Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. | Genes Dis | 2023 | 37397540 | PubTator, text mining | PubMed |
| The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway. | Front Med (Lausanne) | 2023 | 37396899 | PubTator, text mining | PubMed |
| A comprehensive insight into the correlation between ncRNAs and the Wnt/β-catenin signalling pathway in gastric cancer pathogenesis. | Cell Commun Signal | 2023 | 37386429 | PubTator, text mining | PubMed |
| Can Dietary Actives Affect miRNAs and Alter the Course or Prevent Colorectal Cancer? | Int J Mol Sci | 2023 | 37373289 | PubTator, text mining | PubMed |
| P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer. | Neoplasia | 2023 | 37348428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8324/papers?page=10